title: Nimodipine plus zidovudine versus zidovudine alone in the treatment of HIV-1-associated cognitive deficits.
authors.forename: S
authors.initials: S
authors.lastname: Galgani
authors.forename: P
authors.initials: P
authors.lastname: Balestra
authors.forename: P
authors.initials: P
authors.lastname: Narciso
authors.forename: V
authors.initials: V
authors.lastname: Tozzi
authors.forename: P
authors.initials: P
authors.lastname: Sette
authors.forename: F
authors.initials: F
authors.lastname: Pau
authors.forename: G
authors.initials: G
authors.lastname: Visco
mesh_terms: D015526:AIDS Dementia Complex / Q000188:drug therapy*; D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000627:therapeutic use*; D016022:Case-Control Studies; D003071:Cognition / Q000187:drug effects; D004359:Drug Therapy, Combination; D006801:Humans; D008875:Middle Aged; D009483:Neuropsychological Tests; D009553:Nimodipine / Q000008:administration & dosage / Q000627:therapeutic use*; D015215:Zidovudine / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D002121:Calcium Channel Blockers; D015215:Zidovudine; D009553:Nimodipine